β-Carotene, Lycopene Prevent Dermatitis in Murine Model

This article originally appeared here.
Share this content:
β-Carotene, Lycopene Prevent Dermatitis in Murine Model
β-Carotene, Lycopene Prevent Dermatitis in Murine Model

THURSDAY, March 24, 2016 (HealthDay News) -- Oral administration of β-carotene or lycopene prevents atopic dermatitis (AD)-like dermatitis in HR-1 hairless mice, according to an experimental study published online March 19 in the Journal of Dermatology.

Makiko Hiragun, M.D., Ph.D., from Hiroshima University in Japan, and colleagues examined the effect of oral administration of β-carotene or lycopene on AD-like symptoms of HR-1 hairless mice fed with a low zinc/magnesium diet. Mice were divided into four groups and fed for eight weeks with a standard diet; low zinc/magnesium diet (HR group); low zinc/magnesium and β-carotene diet (HR-C group); and low zinc/magnesium and lycopene diet (HR-L group).

The researchers found that in the HR group, mice developed clinical and histological AD-like dermatitis. Xerosis and wrinkle-like skin changes developed in the HR-C and HR-L groups, but they were milder than in those of HR group mice. Epidermis thickening and inflammatory cell infiltration in the skin was statistically less in the HR-C and HR-L versus the HR group. Compared with the HR group, the concentration of thymus and activation regulated chemokine in the skin of the HR-L group and concentration of CCL27 in the skin of the HR-C group were significantly lower.

"In conclusion, per os administration of β-carotene or lycopene prevents AD-like symptoms in association with a suppression of T-helper 2 chemokines in a murine model," the authors write. "Ingestion of carotenoids may be beneficial for patients with AD."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »